FirasEl ChaerMD
Hematology • Charlottesville, VAAssistant Professor of Medicine and Infusion Center Medical Director
Dr. El Chaer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
University of Virginia Health System
PO Box 800716
Charlottesville, VA 22908Phone+1 434-924-9333Fax+1 434-244-7526
Summary
- Dr. Firas El Chaer is an oncologist and hematologist in Charlottesville, VA and is affiliated with the University of Virginia Medical Center. He received his medical degree from University of Balamand Faculty of Medicine and has been in practice 5 years. He also speaks multiple languages, including English, Arabic and French. He is experienced in myeloproliferative disorders, aplastic anemia, acute leukemia, myelodysplastic syndromes, bone marrow failure syndromes, chronic myeloid leukemia and general internal medicine.
Education & Training
University of MarylandFellowship, Hematology and Medical Oncology, 2016 - 2019
Baylor College of MedicineFellowship, Infectious Disease, 2014 - 2016
University of Texas Health Science Center at HoustonFellowship, Infectious Disease, 2014 - 2016
Hackensack University Medical Center/Englewood Hospital and Medical CenterResidency, Internal Medicine, 2011 - 2014
University of Balamand Faculty of MedicineClass of 2011
Certifications & Licensure
VA State Medical License 2018 - 2026
NJ State Medical License 2012 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Internal Medicine Residency Inpatient Attending of the Year University of Virginia, 2022
- Department of Medicine Excellence in Research Award University of Virginia, 2021
- Fellow Teaching Award University of Maryland Medical Center, 2018
- Join now to see all
Clinical Trials
- A Pilot Trial Using Isatuximab to Overcome Platelet Transfusion Refractoriness in Human Leukocyte Antigen Allo-Immunized Patients (SuppCare 001) Start of enrollment: 2022 Nov 29
- Palliative Care Oncology in Patients With Relapsed, Refractory, and High-Risk Leukemias or MDS Start of enrollment: 2020 Aug 19
Publications & Presentations
PubMed
- 20 citationsHow I treat AML incorporating the updated classifications and guidelines.Firas El Chaer, Christopher S Hourigan, Amer M Zeidan
Blood. 2023-06-08 - 47 citationsMLL-Rearranged Acute Lymphoblastic Leukemia.Firas El Chaer, Michael Keng, Karen K. Ballen
Current Hematologic Malignancy Reports. 2020-04-01 - 123 citationsHow i treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipientsFiras El Chaer, Dimpy P. Shah, Roy F. Chemaly
Blood. 2016-12-08
Press Mentions
How Targeted Therapies are Affecting the Cancer Care Team: A Conversation With Dr. Firas El ChaerFebruary 25th, 2020
The role of post-transplant maintenance therapy in AMLMay 25th, 2022
Advances & unmet needs in APLMay 25th, 2022
Committees
- Member, Data and Safety Monitoring Committee 2021 - Present
- Member, Diversity, Equity and Inclusion (DEI) Committee 2021 - Present
- Member, Protocol Review Committee 2020 - Present
- Member, Commission on Cancer 2020 - Present
- Member, Fellowship Program Evaluation Committee 2020 - Present
- Member, Fellowship Selection Committee 2020 - Present
Professional Memberships
- Member
- The American Society for Transplantation and Cellular TherapyMember
Other Languages
- Arabic, French
External Links
- UVA Healthhttps://uvahealth.com/findadoctor/profile/firas-el-chaer
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
